1Imbert T F. Discovery of podophyllotoxin[J]. Biochimie, 1998, 80:207-222.
2Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient,bedside,clinical score for risk assessment at presentation. An intravenous nPA for treatment of infarcting myocardium early Ⅱ trial substudy. Circulation, 2000, 102:2031-2037.
3Antman EM. Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A trial. Circulation, 1996,94: 911-921.
4Uretsky BF,Farquhar DS,Berezin AF,et al.Symptomatic myocardial infarction without chest pain: prevalence and clinical course. The American Journal of Cardiology . 1977
5Tresch DD.Atypical presentations of cardiovascular disorders in the elderly. Geriatrics . 1987
6Simes RJ,Topol EJ,Holmes DRJ,et al.Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: importance of early and complete infarct artery reperfusion. Circulation . 1995
7Dracup K,Moser D K,Eisenberg M,et al.Causes of delay in seeking treatment for heart attack symptoms. Social Science and Medicine . 1995
8Mehta RH,Rathore SS,Radford MJ,et al.Acute myocardial infarction in the elderly: differences by age. Journal of the American College of Cardiology . 2001
9Graff L,Dallara J,Ross MA,et al.Impact on the cane of the emergency department chest pain patient from the Chest Pain Evaluation Registry (CHEPER)study. The American Journal of Cardiology . 1997
10Gomez MA,Anderson JL,Karagounis LA,et al.An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). Journal of the American College of Cardiology . 1996
4Moore R,Pedel S,Lowe R,et al. Health related quality of life following percutaneous coronary intervention:the impact of age on outcome at 1 year[J]. The American Journal of Geriatric Cardiology,2006 ,15(3) : 161-164.
5Hofer S,Doering S,Rumpold G,et al. Determinants of healthrelated quality of life in patients with coronary artery disease [J]. Eur J Cardiovasc Prev Rehabil,2006 Jun, 13(3) :398-406.
6Hlatky MA, Boothroyd DB, Melsop KA, et al. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for muhivessel coronary artery disease[J]. Circulation,2004 , 110(14) : 1960-1966.
7S Schroter, D L Lamping. Coronary revascularization outcome questionnaire (CROQ) development and validation of a new, patient based measure of outcome in coronary bypass surgery and angioplasty[J]. Heart , 2004,90 : 1460-1466.
8Schroter S, Lamping DL. Responsiveness of the coronary revascularisation outcome questionnaire compared with the SF-36 and Seattle Angina Questionnaire[J]. Qual Life Res. 2006 Aug; 15(6) : 1069-78.
9Patrick DL, Wild DJ ,Johnson ES, et al. Cross-cultural validation of quality of life measures[M]. In:Quality of Life Assessment: International Perspectives (Eds. J. Orley and W Kuyken) Berlin/Heidelberg : Springer-Verlag, 1994 : 19-32.
10Hays RD, Anderson R, Revieki D. Psychometric considerations in evaluating health-related quality of life measures[J]. Quality of Life Research, 1993,2 (6) : 441-449.
